stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Oculis Holding AgOCS
$7.923.60%0.275

Oculis Holding Ag (OCS)

Oculis Holding Ag stock is traded at $7.92, with a volume of 8,082. It is up +3.60% in the last 24 hours and up +8.57% over the past month. Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Previous Close:
$7.64
Open:
$7.97
24h Volume:
8,082
Relative Volume:
0.02
Market Cap:
$440.99M
Revenue:
-
Net Income/Loss:
-$117.99M
P/E Ratio:
-
EPS:
-$2.14
Net Cash Flow:
-$79.92M
1W Performance:
+2.00%
1M Performance:
+8.57%
6M Performance:
-73.87%
1Y Performance:
-59.62%
1-Day Range:
$7.77$8.21
1-Week Range:
$7.28$8.21
52-Week Range:
$6.78$34.48

Oculis Holding Ag Stock (OCS) Company Profile

Name
Oculis Holding Ag
Phone
-
Address
Switzerland
Employee
60
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
OCS's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Oculis Holding Ag Stock (OCS) Financials Data

Similar to OCS